Litcius/Paper detail

Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer

Gabriel A. Brooks, Stephanie Tapp, Allan T. Daly, Jonathan A. Busam, Anna N.A. Tosteson

2022Clinical Colorectal Cancer40 citationsDOIOpen Access PDF

Topics & Concepts

DPYDMedicineDihydropyrimidine dehydrogenaseCapecitabineColorectal cancerGenotypingOncologyInternal medicineFluorouracilChemotherapyPharmacogeneticsCancerGenotypeThymidylate synthaseBiologyGeneticsGeneColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancerBiochemical and Molecular Research
Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer | Litcius